Interrelation between alpha 2-adrenoreceptor system and neuropeptide Y in rat nucleus tractus solitarii.
In several systems, alpha 2-adrenoreceptor agonists and neuropeptide Y (NPY) potentiate one another. We reported recently that NPY is a potent depressor agent in the nucleus tractus solitarii (NTS). The purpose of this study is to investigate the possible modulation of the agonist effect by NPY in this site. Microinjection (60nl) of NPY, anti-NPY antiserum, the alpha 2 agonist alpha-methylnorepinephrine (alpha-MNE), clonidine, and the alpha 2 antagonists idazoxan and yohimbine were made into the NTS. Administration of idazoxan (0.2 nmol) prior to the injection of NPY (2.3 pmol) attenuated the potent depressor and bradycardic effect of NPY. There was a similar attenuation of yohimbine's effect. Similarly, prior administration of the anti-NPY antiserum attenuated the depressor effect of the central antihypertensive agents, alpha-MNE and clonidine, whereas inactivated antiserum or control normal rabbit serum were not able to attenuate these effects. Even a subdepressor dose of NPY (47 fmol) could potentiate the effect of alpha-MNE. These results demonstrate a reciprocal potentiation of NPY and alpha 2 agonists in the brainstem, and suggest that NPY and catecholamines interact in central cardiovascular regulation.
Tseng
C J
CJ
Department of Pharmacology, National Defense Medical Center, Taiwan, R.O.C.
Ger
L P
LP
Tung
C S
CS
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D003000:Clonidine / Q000494:pharmacology; D004146:Dioxanes / Q000494:pharmacology; D006339:Heart Rate / Q000187:drug effects; D019329:Idazoxan; D007116:Immunization, Passive; D007700:Kinetics; D008297:Male; D008526:Medulla Oblongata / Q000187:drug effects / Q000502:physiology*; D009478:Neuropeptide Y / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D008771:Nordefrin / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*; D015016:Yohimbine / Q000494:pharmacology
D004146:Dioxanes; D009478:Neuropeptide Y; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D003000:Clonidine; D008771:Nordefrin; D019329:Idazoxan